Back to search

Article

Integrative modeling of multi-omics data for predicting tumor mutation burden in lung cancer patients

2020-07-22

Abstract excerpt

<title>Abstract</title> <p>Background Immunotherapy has been widely used in the treatment of lung cancer, and one of the most effective biomarker for the prognosis of immunotherapy currently is tumor mutation burden (TMB). Although whole-exome sequencing (WES) could be utilized to assess TMB, several problems prevent its routine clinical application. Methods To develop a simplified TMB prediction model, patient...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
096f9298-de42-5a6b-a901-bae5c8f2f3f5
DOI
10.21203/rs.3.rs-45668/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Integrative modeling of multi-omics data for predicting tumor mutation burden in lung cancer patientsDOI 10.21203/rs.3.rs-45668/v1
Integrative Modeling of Multiomics Data for Predicting Tumor Mutation Burden in Patients with Lung Cancer.Semantic proximity
The landscape of tumor mutational burden and its clinical significance in patients with lung cancer: a Multi-omics study with a meta-analysisSemantic proximity
Multi-omics characterization and machine learning of lung adenocarcinoma molecular subtypes to guide precise chemotherapy and immunotherapy.Semantic proximity
Exploration of Tumor Mutation Burden Combined with Immune Infiltrates in the Prognosis of Lung AdenocarcinomaSemantic proximity
Integrated multi-omics analysis and machine learning to refine molecular subtypes, prognosis, and immunotherapy in lung adenocarcinomaSemantic proximity
Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung AdenocarcinomaSemantic proximity
Association Between Tumor Mutation Burden (TMB) and immune microenvironment in lung squamous cell carcinomaSemantic proximity
A novel tumor mutational burden estimation model as a predictive and prognostic biomarker in NSCLC patients.Semantic proximity
Molecular Subtyping and Prognostic Assessment Based on Tumor Mutation Burden in Patients with Lung AdenocarcinomasSemantic proximity
Multi-omics Data Analyses Construct TME and Identify the Immune-Related Prognosis Signatures in Human LUADSemantic proximity
Integrated Multi-Omics Analysis of Lung Adenocarcinoma (TCGA-LUAD): A Comprehensive Study of Genomic, Epigenomic, Copy Number Variations, and Transcriptomic AlterationsSemantic proximity
Identification of tumor mutation burden-associated molecular and clinical features in cancer by analyzing multi-omics data.Semantic proximity
Select a neighboring publication to make it the new centre.